In a groundbreaking first, psilocybin is entering gastroenterology. Dr. Erin Mauney leads a pioneering study exploring how psychedelic therapy could transform treatment for millions suffering from treatment-resistant Irritable Bowel Syndrome, offering new hope for gut-brain disorders.
Here, First Fence discusses whether the key to the crisis lies in revamping our high streets, and explains how brick-and-mortar stores can continue to thrive in the age of convenience.
Julius Pröll from the Climate Service Center Germany turns our attention to the importance of bridging the gap between research institutions and commercial multipliers of climate services.
A team based in the University of Cambridge and University College London published a research study to create understanding about development in the adolescent mind.
Daniel Berman, Head of Global Health, Nesta Challenges, highlights the need for radical change in how innovation is funded and prioritised to ensure an antibiotic future given AMR is still climbing, even though behaviours are changing.
Dr. S. Vincent Grasso, Global Practice Lead: Healthcare & Life Sciences at IPsoft discusses how artificial intelligence (AI) may hold the key to solving the obesity epidemic and relieving pressure on healthcare services.
Dr. Jo Gee writes about working with personality disorders through her psychotherapy experience of over 10 years: Read on for what she has to say about mental health treatment.
Peter Ford, Public Sector Industry Principal, Pegasystems discusses how Artificial Intelligence (AI) has the power to inform and improve decision making in the NHS.
Housing Secretary Robert Jenrick MP has announced that councils will receive a further £112 million to go towards the governments rough sleeping programme.
